Prospective study comparing the conventional and same-day strategies to diagnose pulmonary tuberculosis.


Journal

Medecine et maladies infectieuses
ISSN: 1769-6690
Titre abrégé: Med Mal Infect
Pays: France
ID NLM: 0311416

Informations de publication

Date de publication:
Feb 2020
Historique:
received: 06 03 2018
revised: 29 05 2018
accepted: 13 03 2019
pubmed: 16 4 2019
medline: 8 1 2021
entrez: 16 4 2019
Statut: ppublish

Résumé

The WHO recommends same-day sputum smear microscopy for the diagnosis of smear-positive tuberculosis (TB) in countries with high TB burden for earlier diagnosis and treatment, a cornerstone to prevent air-borne transmission. We aimed to compare the conventional strategy (sputum collection on three consecutive days) and the same-day strategy (hour h, h+1, h+2) in France, a country with low TB burden. Over a six-month period, all adult individuals presenting with presumptive smear-positive TB were eligible for the study, registered in https://clinicaltrials.gov/ ID (NCT02961569). Sputum specimens were collected three times the first day, then once on the second day and once on the third day. The concordance between the two strategies regarding smears and cultures were assessed. Of the 131 eligible individuals, 34 were given a TB treatment. Smears from hour h, h+1, h+2, day two and three were negative in 19 of these 34 patients. Positive smears were obtained in 15, 14, 15, 14, and 14 patients at hour h, h+1, h+2, on day two and three, respectively. Concordance regarding smear or culture was good, with Kappa 0.69 and 0.64, respectively. The same-day strategy seems to be a good alternative to the conventional strategy.

Identifiants

pubmed: 30982671
pii: S0399-077X(18)30134-3
doi: 10.1016/j.medmal.2019.03.010
pii:
doi:

Banques de données

ClinicalTrials.gov
['NCT02961569']

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

36-42

Informations de copyright

Copyright © 2019. Published by Elsevier Masson SAS.

Auteurs

A Lopes (A)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France. Electronic address: amanda.lopes@aphp.fr.

F Mougari (F)

Service de microbiologie, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

D Chopin (D)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

M Pogliaghi (M)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

A-L Munier (AL)

Département de maladies infectieuses, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

V Delcey (V)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

G Simoneau (G)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

L Raskine (L)

Service de microbiologie, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

J Evans (J)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

S Mouly (S)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

E Cambau (E)

Service de microbiologie, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

J-F Bergmann (JF)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

P Sellier (P)

Département de médecine interne, université Paris Diderot, groupe hospitalier Saint-Louis-Lariboisière-Fernand-Widal, Assistance publique-Hôpitaux de Paris (AP-HP), 2, rue Ambroise-Paré, 75010 Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH